Mycotopia Therapies, Inc. Stock

Equities

TPIA

US62846W1071

Delayed OTC Markets Other stock markets 03:13:05 2024-04-23 pm EDT			5-day change	1st Jan Change
0.058 ^USD	+29.00%		-23.75%	+263.12%

Apr. 23	Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Financials (USD)

Sales 2022	-	Sales 2023	-	Capitalization	238K
Net income 2022	-2M	Net income 2023	-1M	EV / Sales 2022	-
Net Debt 2022	269K	Net Debt 2023	2.81M	EV / Sales 2023	-
P/E ratio 2022	-0.94 x	P/E ratio 2023	-0.2 x	Employees	1
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Mycotopia Therapies, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Mycotopia Therapies, Inc.

Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-14	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	23-02-15	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	22-05-23	CI
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market	22-05-02	CI
Mycotopia Therapies Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-14	CI
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt	22-04-13	CI
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc	22-03-17	CI

More news

Press releases Mycotopia Therapies, Inc.

Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million	Dec. 04	AQ
Mycotopia Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K	23-05-03	PU
MYCOTOPIA THERAPIES, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	23-05-03	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	23-03-30	AQ
MYCOTOPIA THERAPIES, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-22	AQ